# C_2021262EN.01002101.xml

| 5.7.2021 | EN | Official Journal of the European Union | C 262/21 |
| --- | --- | --- | --- |

5.7.2021

EN

Official Journal of the European Union

C 262/21

---

Prior notification of a concentration

(Case M.10255 — Triton/Bergman Clinics)

(Text with EEA relevance)

(2021/C 262/09)

1.

This notification concerns the following undertakings:

| — | Triton group (‘Triton’, Jersey), |
| --- | --- |

—

Triton group (‘Triton’, Jersey),

| — | Bergman Healthcare Clinics B.V. (‘Bergman Clinics’, the Netherlands), |
| --- | --- |

—

Bergman Healthcare Clinics B.V. (‘Bergman Clinics’, the Netherlands),

Triton acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Bergman Clinics.

The concentration is accomplished by way of purchase of shares.

2.

| — | for Triton: private equity fund investing primarily in medium-sized businesses headquartered in Central and Northern Europe, with a particular focus on businesses in four core sector, namely Business Services, Industrials, Consumer and Health. One of Triton’s portfolio companies, Aleris Group AB, is active in the provision of ophthalmological services in both Sweden and Norway, |
| --- | --- |

—

for Triton: private equity fund investing primarily in medium-sized businesses headquartered in Central and Northern Europe, with a particular focus on businesses in four core sector, namely Business Services, Industrials, Consumer and Health. One of Triton’s portfolio companies, Aleris Group AB, is active in the provision of ophthalmological services in both Sweden and Norway,

| — | for Bergman Clinics: focus clinics operating throughout the Netherlands, Sweden, Denmark, Norway and Germany offering plannable medical care in the fields of orthopaedics, ophthalmology, gynaecology, aesthetic medicine, cardiology, gastroenterology, dermatology and vascular medicine. One of Bergman Clinics’ portfolio companies, Memira AB, is active in the provision of ophthalmological services across the Nordic countries. |
| --- | --- |

—

for Bergman Clinics: focus clinics operating throughout the Netherlands, Sweden, Denmark, Norway and Germany offering plannable medical care in the fields of orthopaedics, ophthalmology, gynaecology, aesthetic medicine, cardiology, gastroenterology, dermatology and vascular medicine. One of Bergman Clinics’ portfolio companies, Memira AB, is active in the provision of ophthalmological services across the Nordic countries.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10255 — Triton/Bergman Clinics

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---